podophyllotoxin has been researched along with Bacterial Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adimulam, LS; Akula, A; Anagani, SR; Avupati, VR; Doddi, BR; Guntuku, GS; Vutla, VR; Vyricharla, AK; Yejella, RP | 1 |
| Barbon Gauro, J; Heng, MS; Thomas, J; Yaxley, A | 1 |
| Blijham, G; Dicke, KA; Litam, J; McCredie, KB; Samuels, ML; Spitzer, G; Vellekoop, L; Verma, DS; Zander, AR | 1 |
| Bodey, GP; Cabanillas, F; Freireich, EJ; Hagemeister, FB | 1 |
1 trial(s) available for podophyllotoxin and Bacterial Disease
| Article | Year |
|---|---|
The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support.
Topics: Adult; Bacterial Infections; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Humans; Male; Podophyllotoxin; Testicular Neoplasms | 1981 |
3 other study(ies) available for podophyllotoxin and Bacterial Disease
| Article | Year |
|---|---|
Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
Topics: Animals; Anti-Infective Agents; Artemia; Bacteria; Bacterial Infections; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fungi; Humans; Hypoglycemic Agents; Male; Molecular Docking Simulation; Mycoses; Rats; Rats, Wistar; Thiazolidinediones; Toxicity Tests | 2012 |
Does a neutropenic diet reduce adverse outcomes in patients undergoing chemotherapy?
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Carmustine; Chemotherapy-Induced Febrile Neutropenia; Cytarabine; Diet Therapy; Enterocolitis, Neutropenic; Female; Hematologic Neoplasms; Humans; Idarubicin; Male; Melphalan; Middle Aged; Neutropenia; Podophyllotoxin; Retrospective Studies; South Australia | 2020 |
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Inflammation; Lymphoma; Methotrexate; Mucous Membrane; Neutropenia; Podophyllotoxin; Recurrence | 1982 |